Form 8-K · Current report

Illumina, Inc. 8-K, filed Aug 17, 2026

Filed
CIK
0001110803
Accession no.
0001193125-26-354010
AI-generated summary

Summary

Illumina completed a public offering of $300 million aggregate principal amount of 4.950% notes due 2029 on August 17, 2026, and expects to use the net proceeds together with cash on hand to repay its 4.650% notes due September 9, 2026, of which $500 million was outstanding as of June 28, 2026.

Key points

  • The notes accrue interest at 4.950% per annum, payable semi-annually, and mature on September 19, 2029.
  • Illumina expects to use the net proceeds plus cash on hand to repay its 4.650% notes due September 9, 2026, of which $500 million was outstanding as of June 28, 2026.
  • The offering was registered on a Form S-3 registration statement, with the notes issued under an indenture dated March 12, 2021 with U.S. Bank Trust Company, National Association as trustee.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 8.01Other Events
  • 9.01Financial Statements and Exhibits

From the filing

Item 8.01. Other Events. On August 17, 2026, Illumina, Inc. (“Illumina” or the “Company”) completed a public offering of $300,000,000 aggregate principal amount of its 4.950% notes due 2029 (the “Notes”). Illumina expects to use the net proceeds from the offering, together with cash on hand, to repay its 4.650% notes due September 9, 2026, of which $500 million aggregate principal amount was outstanding as of June 28, 2026. The Notes were issued pursuant to an Indenture (the “Indenture”), dated March 12, 2021, between the Company and U.S. Bank Trust Company, National Association, as successor in interest to U.S. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Illumina, Inc. in Readster

Add Illumina, Inc. to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.